204 related articles for article (PubMed ID: 34113337)
1. Altered Immune Phenotypes and
Devi-Marulkar P; Moraes-Cabe C; Campagne P; Corre B; Meghraoui-Kheddar A; Bondet V; Llibre A; Duffy D; Maillart E; Papeix C; Pellegrini S; Michel F
Front Immunol; 2021; 12():628375. PubMed ID: 34113337
[TBL] [Abstract][Full Text] [Related]
2. HLA class I and II alleles and response to treatment with interferon-beta in relapsing-remitting multiple sclerosis.
Comabella M; Fernández-Arquero M; Río J; Guinea A; Fernández M; Cenit MC; de la Concha EG; Montalban X
J Neuroimmunol; 2009 May; 210(1-2):116-9. PubMed ID: 19349081
[TBL] [Abstract][Full Text] [Related]
3. HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
Mazdeh M; Taheri M; Sayad A; Bahram S; Omrani MD; Movafagh A; Inoko H; Akbari MT; Noroozi R; Hajilooi M; Solgi G
Pharmacogenomics; 2016 Apr; 17(5):489-98. PubMed ID: 27020477
[TBL] [Abstract][Full Text] [Related]
4. HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
Samadzadeh S; Tabibian E; Sabokbar T; Shakoori A; Dehgolan SR; Armaki SA; Aslanbeigi B; Abolfazli R
J Neurol Sci; 2015 May; 352(1-2):37-40. PubMed ID: 25824849
[TBL] [Abstract][Full Text] [Related]
5. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.
Chiarini M; Serana F; Zanotti C; Capra R; Rasia S; Rottoli M; Rovaris M; Caputo D; Cavaletti G; Frigo M; Frigeni B; Clerici R; Rezzonico M; Caimi L; Imberti L
Mult Scler; 2012 Jun; 18(6):788-98. PubMed ID: 22086901
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of TYK2, CBLB and LMP7 genes expression in relapsing-remitting multiple sclerosis patients treated with interferon-beta.
Mazdeh M; Moradi N; Khoshroo E; Shayesteh Z; Taheri M; Sayad A; Omrani MD; Hajilooi M; Roshanaei G; Solgi G
J Neuroimmunol; 2018 Jan; 314():24-29. PubMed ID: 29157944
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.
Vosslamber S; van der Voort LF; van den Elskamp IJ; Heijmans R; Aubin C; Uitdehaag BM; Crusius JB; van der Pouw Kraan TC; Comabella M; Montalban X; Hafler DA; De Jager PL; Killestein J; Polman CH; Verweij CL
Genes Immun; 2011 Sep; 12(6):466-72. PubMed ID: 21471993
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis.
Fattahi M; Rezaei N; Nematalahi FS; Shaygannejad V; Fouladi S; Karimi L; Fathi F; Dehghani L; Mirmosayyeb O; Eskandari N
Mult Scler Relat Disord; 2019 Oct; 35():241-245. PubMed ID: 31421628
[TBL] [Abstract][Full Text] [Related]
11. EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy.
Comabella M; Kakalacheva K; Río J; Münz C; Montalban X; Lünemann JD
Mult Scler; 2012 May; 18(5):605-9. PubMed ID: 22020417
[TBL] [Abstract][Full Text] [Related]
12. Human Commensal
Shahi SK; Jensen SN; Murra AC; Tang N; Guo H; Gibson-Corley KN; Zhang J; Karandikar NJ; Murray JA; Mangalam AK
Front Immunol; 2020; 11():578648. PubMed ID: 33362764
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosis.
Charbit H; Benis A; Geyshis B; Karussis D; Petrou P; Vaknin-Dembinsky A; Lavon I
J Clin Neurosci; 2015 Jun; 22(6):986-9. PubMed ID: 25882258
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis.
Fusco C; Andreone V; Coppola G; Luongo V; Guerini F; Pace E; Florio C; Pirozzi G; Lanzillo R; Ferrante P; Vivo P; Mini M; Macrì M; Orefice G; Lombardi ML
Neurology; 2001 Dec; 57(11):1976-9. PubMed ID: 11739812
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
de Andrés C; Aristimuño C; de Las Heras V; Martínez-Ginés ML; Bartolomé M; Arroyo R; Navarro J; Giménez-Roldán S; Fernández-Cruz E; Sánchez-Ramón S
J Neuroimmunol; 2007 Jan; 182(1-2):204-11. PubMed ID: 17157927
[TBL] [Abstract][Full Text] [Related]
16. HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.
Derdelinckx J; Nkansah I; Ooms N; Van Bruggen L; Emonds MP; Daniëls L; Reynders T; Willekens B; Cras P; Berneman ZN; Cools N
Cells; 2020 Dec; 9(12):. PubMed ID: 33348629
[TBL] [Abstract][Full Text] [Related]
17. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.
Korporal M; Haas J; Balint B; Fritzsching B; Schwarz A; Moeller S; Fritz B; Suri-Payer E; Wildemann B
Arch Neurol; 2008 Nov; 65(11):1434-9. PubMed ID: 19001161
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate.
Boziki M; Lagoudaki R; Melo P; Kanidou F; Bakirtzis C; Nikolaidis I; Grigoriadou E; Afrantou T; Tatsi T; Matsi S; Grigoriadis N
J Neurol Sci; 2019 Jun; 401():43-50. PubMed ID: 31009931
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
20. Aligned Expression of IFI16 and STING Genes in RRMS Patients' Blood.
Helbi S; Ravanbakhsh B; Karimi M; Kooti W; Jivad N
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):878-886. PubMed ID: 31362682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
